The Food and Drug Administration (FDA) has announced that it is limiting use of Johnson & Johnson’s COVID-19 vaccine over concerns of rare side effects including blood clots.
The FDA announced on Thursday that it was restricting authorized use of the vaccine, which is produced by the Johnson & Johnson-owned company Janssen Pharmaceuticals, to adults age 18 and over who would not otherwise become vaccinated against COVID. The agency said that the risk of the vaccine causing thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially fatal blood clotting condition, “warrants” limiting its use.
Read more at Newsweek.com
What Are Your Thoughts?
